OUR PRODUCTS
OUR PRODUCTS
OUR PRODUCTS
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
MOLECULAR TUMOR BOARD
GenomOncology’s Molecular Tumor Board enables clinicians to make treatment decisions through a fully integrated workflow that provides alteration-specific content matched to the patient's molecular and clinical history. Clinicians can create, edit, and present cases during a Molecular Tumor Board meeting, creating a final report to include in a patient's EHR record. With the ability to be implemented on-premise or in the cloud, the GenomOncology Molecular Tumor Board can automate your Tumor Board process and provide relevant, meaningful content to inform a patient's treatment plan.
Enhance clinical decision support in a molecular tumor board setting, or at the point of care.
STREAMLINE THE MOLECULAR TUMOR BOARD PROCESS
GenomOncology's Molecular Tumor Board solution eliminates the time-consuming, often manual process associated with setting up and running a molecular tumor board. Our innovative Molecular Tumor Board solution streamlines your meeting process and creates efficiencies to allow you to focus on patient care.
WHAT WE ENABLE YOU TO DO
Variant Information
Our tool compiles in-depth variant information from a number of different databases using our complex biomarker ontology to help you assess the significance of variants all in one view.
Match Results
Our sophisticated match results are based on the patient's molecular variant data coupled with clinical data to provide highly relevant recommendations.
Curated Clinical Trial Eligibilities
With our solution, you have access to all biomarker-based clinical trials curated through our in-house curation team and partnerships with leading content institutions, such as Vanderbilt University's My Cancer Genome.
Curated Therapy Recommendations
Our Molecular Tumor Board enables you to match patients to biomarker-driven therapies, containing all FDA Approvals and Professional Guidelines and literature from leading content institutions.
Separation of
Institutional Trials
Our tool enables you to view and prioritize clinical trials offered at your institution separately from trials available at other institutions by integrating with your clinical trial management system.
Wild-type Match and Partial Match
We provide you with additional trials that match to a patient due to the absence of tested alterations and trials that the patient would be eligible for if variants had been tested for.
AUTOMATING YOUR WORKFLOW
CLINICAL DATA
Our tool easily integrates with your clinical data warehouse to extract all relevant case-level, non-molecular information. We can combine this information with molecular data to automatically create cases that can be easily analyzed and reviewed.
MOLECULAR DATA
Our tool can also automatically generate cases upon receiving new files from vendors through Secure File Transfer Protocol (SFTP). It differentiates between vendors and assays for comprehensive variant processing.
FINAL RECOMMENDATIONS
Our solution enables you to capture case-level recommendations to be able to export or send out to EHR systems. Our flexible reporting tools enable you to create case summaries, meeting summaries, and Molecular Tumor Board presentations.